Twist Bioscience Corp TWST

US Biotechnology
$91.55 β–² +0.24% (+$0.22)
🔥 High Short Interest 🎢 High Beta 📅 Earnings This Week
Open $93.07
Prev Close $91.33
Day Range $88.30 – $93.57
52W Range $23.30 – $105.47
Market Cap $5.70B
Beta 2.14
EPS (TTM) $-1.33

πŸ“‹ Company Profile

IndustryBiotechnology
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2018-10-31
Shares Out.62,270,000
Websitetwistbioscience.com/ β†—
Phone13025310855
Employees979
Revenue$110.7M
Gross Profit$57.1M
Net Income-$44.0M
Free Cash Flow-$100.0M
Total Assets$676.2M
Total Liabilities$221.1M
Equity$455.1M
About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Twist Bioscience Corp is a publicly traded company under the ticker symbol TWST on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ“Š Analyst Ratings

16 analysts (2026-07-01)

Strong Buy 7
Buy 8
Hold 1

πŸ“° Latest News for TWST

πŸ‘₯ Related Stocks